Lactacystin activates FLICE (caspase 8) protease and induces apoptosis in Fas-resistant adult T-cell leukemia cell lines

European Journal of Haematology

Volumn 64, Issue 5, 2000, Pages 315-322

  Yamada, Yasuaki ^a   Sugahara, Kazuyuki ^a   Tsuruda, Kazuto ^a   Nohda, Kazuo ^a   Mori, Naoki ^b   Hata, Tomoko ^a   Maeda, Takahiro ^a   Hayashibara, Toshihisa ^a   Joh, Tatsuroh ^a   Honda, Miyuki ^a   Tawara, Masayuki ^a   Tomonaga, Masao ^a   Miyazaki, Yoshitsugu ^a   Kamihira, Shimeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Apoptosis; ATL; Caspase 8; FLICE; Lactacystin; Proteasome

Indexed keywords

CASPASE 3; CASPASE 8; FAS ANTIGEN; LACTACYSTIN; PROTEASOME INHIBITOR; RECOMBINANT INTERLEUKIN 2;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

ACETYLCYSTEINE; ADULT; ANTI-BACTERIAL AGENTS; ANTIGENS, CD95; ANTIGENS, SURFACE; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; CYSTEINE PROTEINASE INHIBITORS; DRUG RESISTANCE; ENZYME ACTIVATION; HUMANS; LACTAMS; LEUKEMIA, T-CELL; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0034066860     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.90110.x     Document Type: Article

References (40)

1. 1. TRAUTH BC, KLAS C, PETERS AM, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-305.
2. 2. YOHEHARA S, ISHII A, YONEHARA M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169:1747-1756.
3. 3. ITOH N, YONEHARA S, ISHII A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
4. 4. NAGATA S, GOLDSTEIN P. The Fas death factor. Science 1995; 267:1449-1456.
5. 5. BOLDIN MP, VARFOLOMEEV EE, PANCER Z, METT IL, CAMONIS JH, WALLACH D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif re-lated to the death domain. J Biol Chem 1995;270:7795-7798.
6. 6. CHINNAIYAN AM, O'ROURKE K, TEWARI M, DIXIT VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-512.
7. 7. MUZIO M, CHINNAIYAN AM, KISCHKEL FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85:817-827.
8. 8. BOLDIN MP, GONCHAROV TM, GOLTSEV YV, WALLACH D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 1996;85:803-815.
9. 9. UCHIYAMA T, YODOI J, SAGAWA K, TAKATSUKI K, UCHINO H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1997;50:481-492.
10. 10. YAMADA Y. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. Blood 1983;61:192-199.
11. 11. POIESZ BJ, RUSCETTI FW, GAZDOR AF, BUNN PA, MINNA JD, GALLO RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
12. 12. YOSHIDA M, MIYOSHI I, HINUMA Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79:2031-2035.
13. 13. DEBATIN KM, GOLDMANN CK, BAMFORD R, WALDMANN TA, KRAMMER PH. Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia. Lancet 1990;335:497-500.
14. 14. KAMIHIRA S, YAMADA Y, HIRAKATA Y, et al. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias. Br J Haematol 1997;99:858-865.
15. 15. OMURA S, FUJIMOTO T, OTOGURO K, et al. Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J Antibiot 1991;44:113-116.
16. 16. OMURA S, MATSUZAKI K, FUJIMOTO K, et al. Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells. J Antibiot 1991;44:117-118.
17. 17. FENTEANY G, STANDAERT RF, LANE WS, CHOI S, COREY EJ, SCHREIBER SL. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995;268:726-731.
18. 18. FUJITA E, MUKASA T, TSUKAHARA T, ARAHATA K, OMURA S, MOMOI T. Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors. Biochem Biophys Res Commun 1996;224:74-79.
19. 19. IMAJOH-OHMI S, KAWAGUCHI T, SUGIYAMA S, TANAKA K, OMURA S, KIKUCHI H. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem Biophys Res Commun 1995;217:1070-1077.
20. 20. GRIMM LM, GOLDBERG AL, POIRIER GG, SCHWARTZ LM, OSBORNE BA. Proteasomes play an essential role in thymocyte apoptosis. EMBO J 1996;15:3835-3844.
21. 21. HIRSCH T, DALLAPORTA B, ZAMZAMI N, et al. Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis. J Immunol 1998;161:35-40.
22. 22. CUI H, MATSUI K, OMURA S, SCHAUER SL, MATULKA RA, SONENSHEIN GE, JU ST. Proteasome regulation of activation-induced T cell death. Proc Natl Acad Sci USA 1997;94: 7515-7520.
23. 23. YAMADA Y, FUJITA M, SUZUKI H, et al. Established IL-2-dependent double-negative (CD4-/CD8-) TCR αβ/ CD3+ ATL cells: induction of CD4 expression. Br J Haematol 1994;88:234-241.
24. 24. HATA T, FUJIMOTO T, TSUSHIMA H, et al. Multiclonal expansion of unique human T-lymphotropic virus type-1-infected T cells with high growth potential in response to interleukin-2 in prodromal phase of adult T cell leukemia. Leukemia 1999; 13:215-221.
25. 25. KOHNO T, YAMADA Y, HATA T, et al. Relation of oxidative stress and glutathione synthesis to CD95 (Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. J Immunol 1996;156:4722-4728.
26. 26. LANDOWSKI TH, GLEASON-GUZMAN MC, DALTON WS. Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 1997;89:1854-1861.
27. 27. LOS M, HERR I, FRIESEN C, FULDA S, SCHULZE-OSTHOFF K, DEBATIN KM. Cross-resistance of CD95-and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood 1997;90:3118-3129.
28. 28. SAITO Y, TSUBUKI S, ITO H, KAWASHIMA S. The structure-function relationship between peptide aldehyde derivatives on initiation of neurite outgrowth in PC12h cells. Neurosci Lett 1990;120:1-4.
29. 29. HASEGAWA J, KAMADA S, KAMIIKE W, et al. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res 1996;56:1713-1718.
30. 30. MAEDA T, YAMADA Y, MORIUCHI R, et al. Fas gene mutation in the progression of adult T-cell leukemia. J Exp Med 1999;189:1063-1071.
31. 31. TAMIYA S, ETOH K, SUZUSHIMA H, TAKATSUKI K, MATSUOKA M. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood 1998;91:3935-3942.
32. 32. VAUX DL, CORY S, ADAMS JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-442.
33. 33. KLUCK RM, BOSSY-WETZEL E, GREEN DR, NEWMEYER DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275: 1132-1136.
34. 34. CHENG J, ZHOU T, LIU C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263:1759-1762.
35. 35. SATO T, IRIE S, KITADA S, REED JC. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995;268:411-415.
36. 36. SUGAWARA K, YAMADA Y, HIRAGATA Y, et al. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines. Int J Cancer 1997;72:128-132.
37. 37. YAMADA Y, SUGAWARA K, TSURUDA K, et al. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production. Cancer Lett 1999:in press.
38. 38. WANG X, LUO H, CHEN H, DUGUID W, WU J. Role of proteasomes in T cell activation and proliferation. J Immunol 1998;160:788-801.
39. 39. DREXLER HCA. Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci USA 1997;94:855-860.
40. 40. WESSELBORG S, ENGELS IH, ROSSMANN E, LOS M, SCHULZEOSTHOFF K. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ ligand interaction. Blood 1999;93:3053-3063.